Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T CellsIn Situand Lymph Node Metastasis

High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma

(2011) Jocelyne Jacquemier et al.   INTERNATIONAL JOURNAL OF CANCER

IDO inhibits T-cell function through suppressing Vav1 expression and activation

(2010) Runmei Li et al.   CANCER BIOLOGY & THERAPY

Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer

(2009) Aaron S Mansfield et al.   BMC CANCER

Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways

(2008) Vivek Roy et al.   BREAST CANCER RESEARCH AND TREATMENT

Epithelial mesenchymal transition traits in human breast cancer cell lines

(2008) T. Blick et al.   CLINICAL & EXPERIMENTAL METASTASIS

The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: Clinical experience with anti-angiogenic agents, focusing on bevacizumab

(2008) Michel Marty et al.   EUROPEAN JOURNAL OF CANCER

EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy

(2008) Fernanda Milanezi et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape

(2008) Jessica B. Katz et al.   IMMUNOLOGICAL REVIEWS

Immune manipulation of advanced breast cancer: An interpretative model of the relationship between immune system and tumor cell biology

(2008) Andrea Nicolini et al.   MEDICINAL RESEARCH REVIEWS

Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target

(2008) Sandra D Bohling et al.   MODERN PATHOLOGY